Marker Therapeutics, Inc. (MRKR) › RevenueMarker Therapeutics, Inc. (MRKR) — RevenueAnnual figures by period end, from SEC filings.2019-12-31: $213.2K2020-12-31: $466.8K2021-12-31: $1.24M2022-12-31: $3.51M2023-12-31: $3.31M2024-12-31: $6.59M2025-12-31: $3.55M$3.55M2019-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$3.55M-46.2%2026-03-18From 2025-01-012024-12-31$6.59M+99.1%2026-03-18From 2024-01-012023-12-31$3.31M-5.8%2025-03-31From 2023-01-012022-12-31$3.51M+183.0%2024-03-26From 2022-01-012021-12-31$1.24M+166.0%2023-03-22From 2021-01-012020-12-31$466.8K+118.9%2022-03-17From 2020-01-012019-12-31$213.2K—2021-03-09From 2019-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)